CONIOSETIN
Compound with spectra: 2 NMR
| SpectraBase Compound ID | IJdoUdMdQTq |
|---|---|
| InChI | InChI=1S/C25H35NO4/c1-6-7-8-9-18-15(3)13-17-12-14(2)10-11-19(17)25(18,5)23(29)20-22(28)21(16(4)27)26-24(20)30/h6-9,13-14,16-19,21,27,29H,10-12H2,1-5H3,(H,26,30)/b7-6+,9-8+,23-20+/t14-,16?,17+,18-,19-,21?,25-/m1/s1 |
| InChIKey | ISHIUSZGAFLPLK-MSLMHWDWSA-N |
| Mol Weight | 413.6 g/mol |
| Molecular Formula | C25H35NO4 |
| Exact Mass | 413.256609 g/mol |
| Enantiomer InChIKey | ISHIUSZGAFLPLK-SMNGBDKZSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO-D6 |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CD3OD |
CJ-21,058
(20R,22E)-24-NORCHOLESTA-5,22-DIENE-2-BETA,3-ALPHA,21-TRIOL-3,21-DISULFATE
(1S,2R,3S,4S,6S)-4-(ACETOXYMETHYL)-4-HYDROXY-6-[4-(4-METHOXYPHENYL)-1H-1,2,3-TRIAZOL-1-YL]-CYCLOHEXANE-1,2,3-TRIYL-TRIACETATE
(1S,2R,3S,4S,6S)-4-(ACETOXYMETHYL)-6-[4-(4-FLUOROPHENYL)-1H-1,2,3-TRIAZOL-1-YL]-4-HYDROXY-CYCLOHEXANE-1,2,3-TRIYL-TRIACETATE
1,4-Dihydro-1-(0-tolyl)-1-deuterioxy-2,3-dimethoxycarbonylnaphthalene
ethyl 2-({[5-(4-bromophenyl)-7-(trifluoromethyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-2-yl]carbonyl}amino)-6-methyl-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylate
TRICALYSIAMIDE_A
4,5-Secocholest-8-ene-3,5-dione, 14-methyl-
Monotrimethylsilyl 3.beta.,11.beta.-dihydroxy-androst-5-ene-17-one
Cholest-8(14)-en-7-one, 3-hydroxy-, (3.beta.,5.alpha.)-
| Title | Journal or Book | Year |
|---|---|---|
| Coniosetin, a Novel Tetramic Acid Antibiotic from Coniochaeta ellipsoidea DSM 13856. | The Journal of Antibiotics | 2003 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.